期刊文献+

活血降糖饮治疗2型糖尿病气阴两虚证30例 被引量:1

On Treatment of 30 Cases of Type 2 Diabetes with Qi-Yin Deficiency Syndrome by Huoxue Jiangtang Potion
下载PDF
导出
摘要 目的研究活血降糖饮对2型糖尿病气阴两虚患者的治疗作用以及对DPP-4活性的影响。方法我院门诊及住院2型糖尿病患者共60例分为治疗组和对照组各30例,均给予磷酸西格列订口服治疗,治疗组加用活血降糖饮。分别记录年龄、性别、糖尿病病程、治疗前后证候积分、空腹及餐后2小时血糖、空腹及餐后2小时胰岛素、空腹及餐后2小时DPP-4酶活性。结果经治疗两组患者证候积分、空腹及餐后2小时血糖、空腹及餐后2小时DPP-4活性均明显下降,空腹及餐后2小时胰岛素明显升高,差异均有统计学意义(P<0.05,P<0.01);经治疗治疗组证候积分、餐后2小时血糖、餐后2小时胰岛素、餐后2小时DPP-4活性均较对照组降低更加明显,差异有统计学意义(P<0.05,P<0.01);治疗组证候积分、餐后2小时血糖、餐后2小时胰岛素、餐后2小时DPP-4活性治疗前后差值均较对照组明显增加(P<0.05,P<0.01)。结论活血降糖饮可以改善气阴两虚2型糖尿病患者临床症状,降低空腹和餐后血糖,增加空腹和餐后胰岛素分泌,对于餐后血糖和胰岛素的改善作用较空腹更加明显,其作用可能与降低餐后DPP-4酶活性有关。 Objective:To investigate the therapeutical effect of Huoxue Jiangtang potion on patients of type 2 diabetes with qi-yin deficiency syndrome and its effect on DPP-4 activity.Methods:60 patients with type 2 diabetes from both the outpatient and inpatient departments were randomized into treatment group and control group with 30 case in each.Both groups were orally given sitagliptin phosphate and the cases of the treatment group were additionally given Huoxue Jiangtang potion.The patients' age,sex,course of the disease,syndrome integral before and after the treatment,fasting and 2h postprandial blood glucose,fasting and 2h postprandial plasma insulin,fasting and postprandial DPP-4 enzyme activity were recorded.Results:After the treatment,the syndrome integral,fasting and 2hpostprandial blood glucose as well as fasting and postprandial DPP-4 enzyme activity decreased significantly,while the fasting and 2h postprandial plasma insulin increased greatly,the differences had statistical significance(P〈0.05,P〈0.01).The syndrome integral,2h postprandial blood glucose,2h postprandial plasma insulin and 2h postprandial DPP-4 enzyme activity of the treatment group decreased more significantly than those of the control group after the treatment,the differences were statistically significant(P〈0.05,P〈0.01).The differences before and after the treatment in the syndrome integral,2h postprandial blood glucose,2h postprandial plasma insulin and 2h postprandial DPP-4 activity of the treatment group increased more significantly than those of the control group and had statistical significance(P〈0.05,P〈0.01).Conclusion:Huoxue Jiangtang potion can improve the clinical symptoms of patients of type 2 diabetes with qi-yin deficiency,reduce fasting and postprandial blood glucose,increase fasting and postprandial insulin secretion.It is more effective in improving fasting blood glucose and insulin than in postprandial conditions and its effect may be related to reducing postprandial DPP-4 enzyme activity.
作者 刘玲 刘德亮 李惠林 赵恒侠 渠昕 李增英 张学文 Liu Ling Liu Deliang Li Huilin Zhao Hengxia Qu Xin Li Zengying Zhang Xuewen(Shenzhen Hospital of Chinese Medicine, Shenzhen 518033, China Shaanxi University of Chinese Medicine, Xianyang 712046, China)
出处 《现代中医药》 CAS 2017年第5期16-20,共5页 Modern Chinese Medicine
关键词 活血降糖饮 气阴两虚证 2型糖尿病 DPP-4活性 Huoxue Jiangtang potion, qi- yin deficiency syndrome, type 2 diabetes, DPP- 4 enzyme activity
  • 相关文献

参考文献4

二级参考文献24

  • 1李秀钧,董砚虎,程丽霞,柳林.糖尿病研究进展── 第16届国际糖尿病联盟大会纪要[J].中华内分泌代谢杂志,1998,14(2):72-77. 被引量:160
  • 2林兰.中西医结合糖尿病诊疗标准(草案)[J].中国中西医结合杂志,2005,25(1):94-95. 被引量:248
  • 3Ross SA,Eko JM. Incretin agents in type 2 diabetes. Can Fam Physician, 2010,56 (7) : 639-648.
  • 4McKennon SA, Campbell RK. The physiology of incretin hormones and basis for DPP-4 inhibitors. Diabetes Educ, 2007,33 : 55-66.
  • 5VilsbollT, Hoist JJ. Incretins,insulin secretion and type 2 diabetes mellitus. Diabetologia, 2004,47 (3) : 357-366.
  • 6Mclntosh CHS. Incretin-based therapies for type 2 diabetes. Can J Diabetes ,2008,32(2) : 131-139.
  • 7Carr RK, Larsen MO, Jelin K,et al. Secretion and dipetidyl pepti- dase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean,nondiabetic men. J Clin Endocrinol Metab ,2010,95(2) :872-878.
  • 8Varga T,Firneisz G,Nagy G,et al. Elevated serum dipeptidyl pep- tidase-4 activity in type 1 diabetes mellitus: a direct comparison. Orv Hetil, 2010,151 (22) : 899-902.
  • 9R Lugari ,A Del Cas, D Ugolotti, et al. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase 1V (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic di- version. Horm Metab Res,2004,36(2) : 111-115.
  • 10Ryskjaer J,Deacon CF,Carr RD,et al. Plasma dipeptidyl pepti- dase-IV activity in patients with type-2 diabetes mellitus corre- lates positively with HbAlc levels,but is not acutely affected by food intake. Eur J Endocrinol,2006,155:485-493.

共引文献6717

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部